US › Financial Services

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

US · Financial Services · Shell Companies

$10.710.00%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$2.0M
Profit YoY
+57.1%
EPS
$0.06

Key statistics

Market cap
$260.0M
P/E
53.5
Forward P/E
0.0
P/B
1.11
Book value
$-0.22
EPS (TTM)
$0.20
52-week high
$10.72
52-week low
$10.22
50-day MA
$10.64
200-day MA
$10.48

Shareholding

Insiders
23.57%
Institutions
97.52%

Largest institutional holders

FundStake
Karpus Management Inc10.42%
First Trust Capital Management L.P.9.24%
Mizuho Securities USA Inc8.24%
Glazer Capital, LLC6.91%
Westchester Capital Management LLC6.87%
Polar Asset Management Partners6.59%
Wolverine Asset Management LLC6.40%
Highbridge Capital Management, LLC5.45%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Drugs Made In America Acquisition Corp. Ordinary Shares — free to start.

Google PlayApp Store

Other Financial Services companies

Berkshire Hathaway IncBerkshire Hathaway IncJPMorgan Chase & CoVisa Inc. Class AMastercard IncBank of America CorpHSBC Holdings PLC ADRMorgan StanleyGoldman Sachs Group IncRoyal Bank of CanadaWells Fargo & CompanyMitsubishi UFJ Financial Group Inc ADR

Data updated 2026-08-05.